Espinoza Octavio insider trades
Espinoza Octavio has filed 34 Form 4s with the SEC that we hold, all for Ligand Pharmaceuticals INC (LGND), as Chief Financial Officer. Across all of them we count 2 purchases worth $156.1K and 25 sales worth $15.3M reported on Form 4. In the last 12 months: 0 purchases ($0) and 14 sales ($13.0M). The largest single trade was a sale of 31,641 shares of Ligand Pharmaceuticals INC worth $9.2M, dated 2026-08-12. The first filing on our record is dated 2022-11-10 and the latest 2026-08-14.
Ligand Pharmaceuticals INC (LGND)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-11-09 | S, sale reported on Form 4 | 1,696 | $128.3K | 2022-11-10 |
| 2024-02-28 | S, sale reported on Form 4 | 140 | $12.4K | 2024-02-29 |
| 2024-05-15 | S, sale reported on Form 4 | 5,873 | $505.1K | 2024-05-17 |
| 2024-05-16 | S, sale reported on Form 4 | 2,264 | $194.7K | 2024-05-17 |
| 2024-05-17 | S, sale reported on Form 4 | 134 | $11.6K | 2024-05-17 |
| 2024-05-17 | S, sale reported on Form 4 | 5,022 | $435.3K | 2024-05-17 |
| 2024-09-20 | S, sale reported on Form 4 | 200 | $20.8K | 2024-09-24 |
| 2024-09-20 | S, sale reported on Form 4 | 800 | $83.2K | 2024-09-24 |
| 2024-09-20 | S, sale reported on Form 4 | 275 | $28.6K | 2024-09-24 |
| 2024-12-23 | S, sale reported on Form 4 | 2,104 | $244.8K | 2024-12-26 |
| 2025-03-04 | S, sale reported on Form 4 | 5,000 | $575.1K | 2025-03-06 |
| 2025-05-09 | P, purchase reported on Form 4 | 1,000 | $103.9K | 2025-05-13 |
| 2025-05-09 | P, purchase reported on Form 4 | 500 | $52.2K | 2025-05-13 |
| 2025-12-12 | S, sale reported on Form 4 | 1,804 | $339.7K | 2025-12-16 |
| 2026-03-04 | S, sale reported on Form 4 | 950 | $191.6K | 2026-03-06 |
| 2026-03-04 | S, sale reported on Form 4 | 3,413 | $712.6K | 2026-03-06 |
| 2026-03-04 | S, sale reported on Form 4 | 2,457 | $510.8K | 2026-03-06 |
| 2026-03-04 | S, sale reported on Form 4 | 699 | $138.9K | 2026-03-06 |
| 2026-03-04 | S, sale reported on Form 4 | 53 | $10.6K | 2026-03-06 |
| 2026-03-04 | S, sale reported on Form 4 | 698 | $140.4K | 2026-03-06 |
| 2026-03-04 | S, sale reported on Form 4 | 697 | $141.3K | 2026-03-06 |
| 2026-03-04 | S, sale reported on Form 4 | 668 | $136.0K | 2026-03-06 |
| 2026-03-04 | S, sale reported on Form 4 | 743 | $152.1K | 2026-03-06 |
| 2026-03-04 | S, sale reported on Form 4 | 1,457 | $299.8K | 2026-03-06 |
| 2026-03-04 | S, sale reported on Form 4 | 1,588 | $328.5K | 2026-03-06 |
| 2026-03-11 | S, sale reported on Form 4 | 3,057 | $687.8K | 2026-03-13 |
| 2026-08-12 | S, sale reported on Form 4 | 31,641 | $9.2M | 2026-08-14 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1905248) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms